Skip to content

Clinical trials

Hematologic Neoplasms trials in Italy with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Unknown status Country / region: Italy Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20132
20151
20181
20192
20203
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
A.O. Ospedale Papa Giovanni XXIII2
Fondazione del Piemonte per l'Oncologia2
Ospedale di Circolo - Fondazione Macchi2
European Institute of Oncology1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1
Lorenza Scotti1
Maastricht University Medical Center1
Ospedale San Carlo Borromeo1
Protherics Medicines Development Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms17
COVID-192
Acute Kidney Injury1
Cognitive Dysfunction1
Disease1
Drug-Related Side Effects and Adverse Reactions1
Hematologic Diseases1
Leukemia1
Lymphoma1
Multiple Myeloma1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.